Skip to search formSkip to main contentSkip to account menu

Type 1 Papillary Renal Cell Carcinoma

Known as: Papillary renal cell carcinoma type 1, RCCP1, RENAL CELL CARCINOMA, PAPILLARY, 1 
A papillary renal cell carcinoma characterized by the presence of papillae covered by small cells with scant amount of cytoplasm. The cells are… 
National Institutes of Health

Related topics

Related topics

19 relations
Bile Ducts, ExtrahepaticCystic ChangeEpithelial CellsEpithelium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
[Successful Treatment of Peritoneal Dissemination Recurrence with Axitinib in Papillary Renal Cell Carcinoma : A Case Report].
We report a case of successful treatment of recurrence of peritoneal dissemination with axitinib. A 55-year-old man presented at… 
2018
2018
Effect of crizotinib on disease control in patient with advanced papillary renal cell carcinoma type 1 with MET mutations or amplification: Final results of EORTC 90101 CREATE.
580Background: Papillary renal cell carcinoma type 1(PRCC1) is associated with MET alterations. Our phase II trial assessed the… 
2018
2018
Abstract 3842: Potent antitumor activity of the HSP90 inhibitor SNX-2112 in type 1 papillary renal cell carcinoma
Papillary renal-cell carcinoma (pRCC) is the second most common form of kidney cancer, accounting for 15 to 20% of all cases… 
2018
2018
MP28-17 NON-TYPE 1 PAPILLARY RENAL CELL CARCINOMA IS ASSOCIATED WITH A WORST ONCOLOGICAL OUTCOME IN PATIENTS TREATED SURGICALLY
2017
2017
Type 1 papillary renal cell carcinoma: differentiation from Type 2 papillary RCC on multiphasic MDCT
PurposeTo investigate whether multiphasic MDCT enhancement can help differentiate type 1 papillary renal cell carcinoma (RCC… 
2016
2016
Abstract CT006: Crizotinib achieves objective responses and long-lasting disease control in patients (pts) with metastatic papillary renal cell carcinoma type 1 (PRCC1) with somaticMETmutations…
Background: EORTC 90101 prospectively assesses the activity and safety of the ALK/ROS/MET inhibitor Crizotinib in 6 independent… 
Review
2013
Review
2013
Transition of organizational category on renal cancer.
The incidence of kidney cancer is gradually increasing, with a rate of 2-3% per decade. The kidney develops various kinds of… 
2013
2013
Gastrointestinal stromal tumor associated with a different malignant neoplasia.
The gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor in the digestive tract (1). It is accompanied by… 
2012
2012
Synchronous ipsilateral conventional and papillary renal cell carcinoma
2000
2000
Thomsen-Friedenreich glycotope is expressed in developing and normal kidney but not in renal neoplasms.
The Thomsen-Friedenreich glycotope (TF) is considered a general carcinoma autoantigen and is therefore of importance in cancer… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)